Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2024 年第 2 季持倉
持倉截至 2024/6/30，2024/8/14 申報。只含多頭部位，變化是跟 2024 年第 1 季比股數。
- 持股檔數
- 67
- 較 2024 年第 1 季 +2
- 總值
- $33.5 億
- 較 2024 年第 1 季 −$1.30 億 (−3.7%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| AMGNAmgen Inc | Stock | 575,000 | $1.80 億 | 5.4% | +25,000+4.5% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 400,000 | $1.72 億 | 5.1% | +100,000+33.3% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 1,852,784 | $1.49 億 | 4.5% | +548,063+42.0% | 加碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 4,000,000 | $1.41 億 | 4.2% | −555,383−12.2% | 減碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,700,000 | $1.39 億 | 4.2% | +220,147+6.3% | 加碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 2,000,000 | $1.34 億 | 4.0% | −2,783,679−58.2% | 減碼 | 歷史 |
| GHGuardant Health, Inc. | COM | 4,500,000 | $1.30 億 | 3.9% | −1,500,000−25.0% | 減碼 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 10,900,000 | $1.22 億 | 3.7% | +1,758,340+19.2% | 加碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 500,000 | $1.22 億 | 3.6% | −332,310−39.9% | 減碼 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 4,800,000 | $1.07 億 | 3.2% | +589,216+14.0% | 加碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 1,537,922 | $1.05 億 | 3.1% | +37,922+2.5% | 加碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 2,500,000 | $9,590 萬 | 2.9% | +1,500,000+150.0% | 加碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 2,000,000 | $9,532 萬 | 2.8% | +626,525+45.6% | 加碼 | 歷史 |
| OCULOcular Therapeutix, Inc | COM | 12,721,460 | $8,701 萬 | 2.6% | 00.0% | 不變 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 4,061,401 | $8,525 萬 | 2.5% | +1,026,948+33.8% | 加碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 3,500,000 | $8,435 萬 | 2.5% | 00.0% | 不變 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 3,991,500 | $8,330 萬 | 2.5% | +993,670+33.1% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 2,883,736 | $7,613 萬 | 2.3% | +2,390,384+484.5% | 加碼 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 3,490,506 | $7,065 萬 | 2.1% | 00.0% | 不變 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 5,972,257 | $6,420 萬 | 1.9% | +222,257+3.9% | 加碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 7,370,000 | $6,058 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 4,000,000 | $5,784 萬 | 1.7% | +812,585+25.5% | 加碼 | 歷史 |
| ABVXAbivax S.A. | SPONSORED ADS | 4,179,763 | $5,526 萬 | 1.7% | −117,675−2.7% | 減碼 | 歷史 |
| GERNGeron Corp | COM | 13,000,000 | $5,512 萬 | 1.6% | −17,505,929−57.4% | 減碼 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 15,272,172 | $5,315 萬 | 1.6% | 00.0% | 不變 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 2,870,131 | $5,106 萬 | 1.5% | +2,870,131 | 新進 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 3,923,849 | $5,105 萬 | 1.5% | +467,796+13.5% | 加碼 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 1,500,000 | $4,478 萬 | 1.3% | +237,754+18.8% | 加碼 | 歷史 |
| DFTXDefinium Therapeutics, Inc. | Stock | 6,103,817 | $4,401 萬 | 1.3% | −562,850−8.4% | 減碼 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 4,000,000 | $4,328 萬 | 1.3% | +774,581+24.0% | 加碼 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 6,100,000 | $4,154 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 1,756,667 | $4,130 萬 | 1.2% | +543,247+44.8% | 加碼 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 1,000,000 | $3,935 萬 | 1.2% | −1,323,456−57.0% | 減碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 950,000 | $3,731 萬 | 1.1% | +909,863+2,266.9% | 加碼 | 歷史 |
| ANIPAni Pharmaceuticals Inc | COM | 466,089 | $2,968 萬 | 0.9% | −355,912−43.3% | 減碼 | 歷史 |
| EDITEditas Medicine, Inc. | COM | 6,000,000 | $2,802 萬 | 0.8% | +472,710+8.6% | 加碼 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 3,904,785 | $2,776 萬 | 0.8% | +3,904,785 | 新進 | 歷史 |
| HLVXHilleVax, Inc. | COM | 1,832,652 | $2,650 萬 | 0.8% | −739,808−28.8% | 減碼 | 歷史 |
| KRROKorro Bio, Inc. | COM | 770,645 | $2,610 萬 | 0.8% | +770,645 | 新進 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 1,359,745 | $2,584 萬 | 0.8% | −284,136−17.3% | 減碼 | 歷史 |
| NKTRNektar Therapeutics | COM | 17,875,498 | $2,217 萬 | 0.7% | −524,502−2.9% | 減碼 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 2,250,000 | $2,122 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ALECAlector, Inc. | COM | 4,631,998 | $2,103 萬 | 0.6% | +862,612+22.9% | 加碼 | 歷史 |
| ETNB89bio, Inc. | COM | 2,294,011 | $1,838 萬 | 0.5% | +2,294,011 | 新進 | 歷史 |
| FATEFate Therapeutics Inc | COM | 5,572,607 | $1,828 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| INOInovio Pharmaceuticals, Inc. | COM SHS | 2,066,720 | $1,670 萬 | 0.5% | +2,066,720 | 新進 | 歷史 |
| PRAXPraxis Precision Medicines, Inc. | COM NEW | 389,546 | $1,611 萬 | 0.5% | +389,546 | 新進 | 歷史 |
| Cybin Ord23256X100 | COM | 58,139,535 | $1,576 萬 | 0.5% | 00.0% | 不變 | – |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $1,488 萬 | 0.4% | +7,419,355 | 新進 | 歷史 |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 4,184,100 | $1,385 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| IVVDInvivyd, Inc. | COM | 10,953,937 | $1,205 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 3,283,783 | $1,149 萬 | 0.3% | +760,783+30.2% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 384,756 | $792.2 萬 | 0.2% | +384,756 | 新進 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 132,495 | $717.9 萬 | 0.2% | +132,495 | 新進 | 歷史 |
| RGLSRegulus Therapeutics Inc. | COM | 3,262,564 | $582.4 萬 | 0.2% | −4,002−0.1% | 減碼 | 歷史 |
| ANROAlto Neuroscience, Inc. | COM SHS | 511,686 | $547.0 萬 | 0.2% | −88,314−14.7% | 減碼 | 歷史 |
| AGENAgenus Inc | COM NEW | 313,359 | $524.9 萬 | 0.2% | −1,271,518−80.2% | 減碼依 1 比 20 拆股換算 | 歷史 |
| ALLKAllakos Inc. | COM | 5,000,000 | $500.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 828,485 | $427.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 1,234,773 | $370.4 萬 | 0.1% | −5,261−0.4% | 減碼 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 186,386 | $335.7 萬 | 0.1% | +186,386 | 新進 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 372,559 | $310.3 萬 | 0.1% | −307,441−45.2% | 減碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 904,261 | $298.4 萬 | 0.1% | −1,780,083−66.3% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 308,235 | $259.8 萬 | 0.1% | −7,765−2.5% | 減碼 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 597,215 | $238.9 萬 | 0.1% | −997,716−62.6% | 減碼 | 歷史 |
| ALGSAligos Therapeutics, Inc. | COM | 6,102,770 | $213.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| MGXMetagenomi Therapeutics, Inc. | COM | 466,232 | $190.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| NMRANeumora Therapeutics, Inc. | COM | – | $177.4 萬 |
2024 年第 1 季之後清倉（8 檔）
2024 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 1 季股數 | 2024 年第 1 季市值 | 2024 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| TRMLTourmaline Bio, Inc. | COM | 1,595,400 | $3,653 萬 | 1.1% | 歷史 |
| PACBPacific Biosciences of California, Inc. | COM | 7,000,000 | $2,625 萬 | 0.8% | 歷史 |
| NUVLNuvalent, Inc. | COM | 274,512 | $2,061 萬 | 0.6% | 歷史 |
| NMRANeumora Therapeutics, Inc. | COM | 1,000,000 | $1,375 萬 | 0.4% | 歷史 |
| ANABAnaptysbio, Inc | COM | 529,452 | $1,192 萬 | 0.3% | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 167,784 | $783.4 萬 | 0.2% | 歷史 |
| MRSNMersana Therapeutics, Inc. | COM | 579,674 | $259.7 萬 | 0.1% | 歷史 |
| PRMEPrime Medicine, Inc. | COM | 303,716 | $212.6 萬 | 0.1% | 歷史 |